US multinational Johnson & Johnson will have to compensate patients in India adversely affected by "faulty" hip replacement surgery using the company's implant with the health ministry asking the drug regulator to set up committees in states to receive complaints.
from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/2MLDyew
0 comments:
Post a Comment